Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with a...
Guardado en:
Autores principales: | Tamara García Camarero, José M de la Torre Hernández |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
por: Charalampos Varlamos, et al.
Publicado: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
por: Iosif Xenogiannis, et al.
Publicado: (2021) -
Antithrombotic Therapy after Venous Stent Placement
por: Nicholas Xiao, et al.
Publicado: (2020)